Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Albers

Showing results (41-50 of 338) with videos related to

Pageof 34
Sort By:
Asian Journal of Urology|May 17, 2021
Surgical treatment of metastatic germ cell cancerAndreas Hiester, Peter Albers
Aktuelle Urologie|August 26, 2025
Peter Albers, Axel Heidenreich
Current Opinion in Urology|July 9, 2011
Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer?Günter Niegisch, Peter Albers
World Journal of Urology|May 17, 2017
Testis cancer: some problems still remain unsolvedPeter Albers, Carsten Bokemeyer
Urologic Oncology|August 5, 2017
Targeting mTOR in urothelial cancer-Beating a dead horse or ready for prime time?Günter Niegisch, Peter Albers
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 5, 2024
[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!]Peter Albers, Nikolaus Becker
Der Urologe. Ausg. A|May 6, 2021
[Prostate cancer screening 2021 : Individualization, informed decision-making and additional diagnostic options are good for the disease and those affected]Maurice Stephan Michel, Peter Albers
World Journal of Urology|April 6, 2004
Late relapse of testicular cancerMartin E Lipphardt, Peter Albers
European Urology|December 16, 2023
Prostate Cancer Screening at its Best: The Swedish Organized Prostate Cancer Testing ProgramPeter Albers, Hendrik van Poppel
European Urology|March 4, 2023
Reply to Kirti Singh, Swarnendu Mandal, Manoj Kumar Das, Prasant Nayak, and Sambit Tripathy's Letter to the Editor re: Andreas Hiester, Yue Che, Achim Lusch, et al. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.10.021Yue Che, Andreas Hiester, Peter Albers
Pageof 34

Showing results (41-50 of 338) with videos related to

Sort By:
Pageof 34
Asian Journal of Urology|May 17, 2021
Surgical treatment of metastatic germ cell cancerAndreas Hiester, Peter Albers
Aktuelle Urologie|August 26, 2025
Peter Albers, Axel Heidenreich
Current Opinion in Urology|July 9, 2011
Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer?Günter Niegisch, Peter Albers
World Journal of Urology|May 17, 2017
Testis cancer: some problems still remain unsolvedPeter Albers, Carsten Bokemeyer
Urologic Oncology|August 5, 2017
Targeting mTOR in urothelial cancer-Beating a dead horse or ready for prime time?Günter Niegisch, Peter Albers
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 5, 2024
[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!]Peter Albers, Nikolaus Becker
Der Urologe. Ausg. A|May 6, 2021
[Prostate cancer screening 2021 : Individualization, informed decision-making and additional diagnostic options are good for the disease and those affected]Maurice Stephan Michel, Peter Albers
World Journal of Urology|April 6, 2004
Late relapse of testicular cancerMartin E Lipphardt, Peter Albers
European Urology|December 16, 2023
Prostate Cancer Screening at its Best: The Swedish Organized Prostate Cancer Testing ProgramPeter Albers, Hendrik van Poppel
European Urology|March 4, 2023
Reply to Kirti Singh, Swarnendu Mandal, Manoj Kumar Das, Prasant Nayak, and Sambit Tripathy's Letter to the Editor re: Andreas Hiester, Yue Che, Achim Lusch, et al. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.10.021Yue Che, Andreas Hiester, Peter Albers
Pageof 34